The case, originally filed in 2021 by Harbour Antibodies, asserted that Amgen and Teneobio (an Amgen subsidiary) infringed patents protecting Harbour's groundbreaking antibody discovery platform Delaware jury finds infringement willful and patent valid, and awards full $20.2 million in...
Hence then, the article about harbour biomed secures landmark victory in u s patent infringement case against amgen reshaping the global antibody patent landscape was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape )
Also on site :
- Biden Loyalist: Platner’s Nazi Tat, Wife-Beating, Pedo App & Rape Fantasies Aren’t Just ‘Transgressions’
- Trump celebrates 80th birthday with a UFC fight at the White House as Americans pay the price for his Iran war
- Republican attorneys general urge EPA to classify mifepristone as water contaminant